Literature DB >> 22014984

Iatrogenic skin injury in hospitalized patients.

Carol E Cheng1, Daniela Kroshinsky.   

Abstract

Iatrogenic skin injuries in hospitalized patients range from drug-related complications to those related to procedures. Common drug complications include drug reaction with eosinophilia and systemic symptoms (DRESS), linear immunoglobulin (Ig) A bullous dermatosis, Stevens-Johnson syndrome/toxic epidermal necrolysis, and acute generalized exanthematous pustulosis. Contact dermatitis can result from surgical preparations of chlorhexidine and povidone-iodine, medical adhesives, topical postsurgical ointments, most commonly neomycin and bacitracin, and internal prostheses, including coronary stents, pacemakers, and metal joints. Complications arising from procedures include thrombosis caused by placement of peripherally inserted central catheters, pyoderma gangrenosum from sites of dermal trauma, and anetoderma of prematurity from cutaneous monitoring devices in neonates. Calcinosis cutis and decubitus ulcers are also hospital problems.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22014984     DOI: 10.1016/j.clindermatol.2011.08.006

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  3 in total

1.  Iatrogenic pressure sores: primum non nocere.

Authors:  Billur Sezgin; Hakan Bulam; Bora Ozel
Journal:  Int Wound J       Date:  2015-10-29       Impact factor: 3.315

2.  Effect of daily chlorhexidine bathing on hospital-acquired infection.

Authors:  Michael W Climo; Deborah S Yokoe; David K Warren; Trish M Perl; Maureen Bolon; Loreen A Herwaldt; Robert A Weinstein; Kent A Sepkowitz; John A Jernigan; Kakotan Sanogo; Edward S Wong
Journal:  N Engl J Med       Date:  2013-02-07       Impact factor: 91.245

3.  Iatrogenic calcinosis cutis secondary to calcium chloride successfully treated with topical sodium thiosulfate.

Authors:  James Abbott; Eric H Kowalski; Stephanie Klein; Rosemary DeShazo; Christopher M Hull
Journal:  JAAD Case Rep       Date:  2020-02-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.